PubMed:31213813 / 2070-2284
Annnotations
GoldHamster
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T211 | 12-15 | PR:O35763 | denotes | MSN |
| T213 | 12-15 | PR:000003008 | denotes | MSN |
| T214 | 12-15 | PR:P26041 | denotes | MSN |
| T215 | 12-15 | PR:P26038 | denotes | MSN |
| T212 | 12-15 | CVCL_9882 | denotes | MSN |
| T216 | 39-42 | CVCL_1K15 | denotes | HER |
| T217 | 39-43 | PR:P04626 | denotes | HER2 |
| T218 | 39-43 | PR:000002082 | denotes | HER2 |
| T219 | 39-43 | PR:Q03557 | denotes | HER2 |
| T220 | 39-43 | PR:P34708 | denotes | HER2 |
| T221 | 39-43 | PR:Q5AK64 | denotes | HER2 |
| T222 | 119-123 | CHEBI:23888 | denotes | drug |
| T223 | 179-182 | CVCL_1K15 | denotes | HER |
| T224 | 179-183 | PR:P04626 | denotes | HER2 |
| T225 | 179-183 | PR:000002082 | denotes | HER2 |
| T226 | 179-183 | PR:Q03557 | denotes | HER2 |
| T227 | 179-183 | PR:P34708 | denotes | HER2 |
| T228 | 179-183 | PR:Q5AK64 | denotes | HER2 |
PubMed_ArguminSci
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T13 | 0-214 | DRI_Outcome | denotes | Conclusion: MSN-BM/CD-HApt@DOX enables HER2-mediated targeting and biotherapeutic effects as well as pH-responsive DOX drug release, resulting in synergistic cytotoxic effects in HER2-overexpressing cells in vitro. |
Goldhamster2_Cellosaurus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T55 | 12-15 | CVCL_9882|Cancer_cell_line|Homo sapiens | denotes | MSN |
| T56 | 16-18 | CVCL_E481|Transformed_cell_line|Homo sapiens | denotes | BM |
| T57 | 16-18 | CVCL_S926|Spontaneously_immortalized_cell_line|Lates calcarifer | denotes | BM |
| T58 | 19-21 | CVCL_5731|Spontaneously_immortalized_cell_line|Mus musculus | denotes | CD |
| T59 | 19-21 | CVCL_W955|Cancer_cell_line|Homo sapiens | denotes | CD |